Search results
Outcomes of CTO PCI in a Non-surgical Centre
Added:
2 years ago
Original Research
Added:
1 week ago
Dr Virag Kushwaha (Eastern Heart Clinic, New South Wales, AU) joins us to discuss 30-day outcomes of valve-in-valve transcatheter aortic valve replacement using the Navitor system in patients with failed surgical aortic bioprosthetic valves.As the population of patients with ageing surgical bioprostheses continues to grow, valve-in-valve TAVR has become an increasingly important treatment pathway…
View more
Added:
2 months ago
Welcome to the introductory segment of Dr Robert Jay Widmer's 'Cath Lab Guide to Coronary Reactivity Testing in Non‑Obstructive CAD'.Dr Widmer (The McKinney Heart Hospital, US) presents the case of a 25-year-old female endurance runner experiencing exertional, band-like chest pain. Her coronary CTA appears normal, while PET imaging reveals mildly reduced flow confined to the circumflex territory…
View more
Coronary Reactivity Testing for Non‑Obstructive CAD
Video Series
The Role of Non-invasive Tests in Pulmonary Embolism
Added:
7 months ago
Review Article
Added:
1 year ago
Dr Luca Testa (IRCCS Policlinico San Donato, IT) discusses the results of the XLIMIT Trial at the EuroPCR 2024 congress in Paris, France.In this video interview, Dr Testa explains the technology behind the XLIMUS® drug-eluting stent (Cardionovum®) and its benefits. He also reviews the XLIMIT Trial, detailing the study design, selection criteria and clinical outcomes.Specifically, the 6 to 9…
View more
Added:
2 months ago
Source:
Interventional Cardiology Review Journal
For patients with atrial fibrillation (AF) at high risk for both stroke and bleeding, catheter-based left atrial appendage closure (LAAC) was not found to be non-inferior to physician-directed best medical care, according to the results of the CLOSURE-AF trial.¹MethodologyThe multicentre, randomised CLOSURE-AF trial was conducted in Germany to assess the effectiveness of LAAC compared with best…
View more
Added:
1 year ago
CRT 25 - Dr S. Chris Malaisrie (Northwestern University, Evanston, US) joins us to discuss the five-year outcomes from the PARTNER 3 aortic valve-in-valve registry (NCT02675114). The prospective, randomized, multi-center study aimed to assess TAVR with the Edwards SAPIEN 3 transcatheter heart valve (Edwards Lifesciences) compared to aortic valve replacement with a commercially available surgical…
View more
Added:
1 year ago
TCT Conference 2024 - Safety and efficacy outcomes of transcatheter aortic valve replacement (TAVR) compared to surgical aortic valve replacement (SAVR) in female patients with severe aortic stenosis.Dr Didier Tchétché (Clinique Pasteur, FR) joins us onsite at TCT Conference to discuss the pooled findings from the RHEIA (NCT04160130) and PARTNER 3 (NCT02675114) trials.RHEIA and PARTNER 3 are…
View more
Added:
1 year ago